# Pre-post Evaluation of the Safety and Efficacy of Ibogaine-Magnesium Therapy in Veterans With Repeated Blast Exposure

> **NCT04313712** · — · ACTIVE_NOT_RECRUITING · sponsor: **Stanford University** · enrollment: 30 (estimated)

## Conditions studied

- Blast or Combat Exposure
- Head Injury Trauma

## Interventions

- **DRUG:** ibogaine with magnesium treatment

## Key facts

- **NCT ID:** NCT04313712
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-11-15
- **Primary completion:** 2025-02
- **Final completion:** 2025-02
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2024-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04313712

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04313712, "Pre-post Evaluation of the Safety and Efficacy of Ibogaine-Magnesium Therapy in Veterans With Repeated Blast Exposure". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04313712. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*